DATE RECALL INITIATED: August 24, 1999 > >PRODUCT
/ LOT NUMBER / QC LOT NUMBER* / EXPIRATION DATE: > >Immune Globulin
Intravenous (Human), Sandoglobulin: >7.409.561.0 561Z4409
07/2000 >7.409.561.0 561Z4098 07/2000 >8.409.362.0 047A6478
04/2001 >8.409.433.0 053A6697 06/2000 >8.409.433.0
053A6698 06/2000 >9.401.255.0 085B9813
01/2001 >8.409.599.0 072A8945 10/2000 >8.409.599.0 072A8946
10/2000 >8.409.208.0 029A6093 12/2000 >9.409.229.0 080B9812
12/2000 >9.401.292.0 090B0161 01/2001 > >*QC lot numbers
appear on the outer folding carton in which the >12 gram bottle is
packaged. > >MANUFACTURER: > >Central Laboratory Blood
Transfusion Service Swiss Red Cross >Bern,
Switzerland > >DISTRIBUTORS: > >Immune Globulin
Intravenous (Human), Sandoglobulin: >Novartis Pharmaceuticals
Corporation >East Hanover, NJ/Suffern,
NY > >REASON: > >Central Laboratory Blood Transfusion
Service Swiss Red Cross has >initiated this recall due to the detection
that certain lots of >Immune Globulin Intravenous (IGIV) have been
released which may >contain bottles having residual moisture content
greater than the >specified limit of 2% residual moisture. No
adverse events have >been reported related to this
issue. > >Additional lots of recalled product are included in the
8/20/99 >notification.
